Uncategorized
Glaukos Announces Participation in Bank of America Merrill Lynch 2018 Health Care Conference
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the Bank of America Merrill Lynch 2018 Health Care Conference on Wednesday, May 16, 2018, at 3:00 p.m. PDT in Las Vegas, Nevada. A live